XML 82 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidating Guarantor Financial Information
12 Months Ended
Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidating Guarantor Financial Information
Consolidating Guarantor Financial Information:
The 2014 Senior Notes issued by Albemarle Corporation (the “Issuer”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Albemarle Holdings Corporation and Albemarle Holdings II Corporation (the “Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned subsidiaries of the Issuer. The guarantees are general senior unsecured obligations of the Guarantor Subsidiaries and rank equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantor Subsidiaries that are not, by their terms, otherwise expressly subordinated. The note guarantees will be released when the 4.625% Senior Notes assumed by Albemarle upon the acquisition of Rockwood are repaid or otherwise discharged.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash between Issuer, Guarantor Subsidiaries and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the years ended December 31, 2014, 2013 and 2012 present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantor Subsidiaries to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Issuer, Guarantor Subsidiaries, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described in the notes to the consolidated financial statements.
Consolidating Balance Sheet
December 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1,930,802

 
$

 
$
558,966

 
$

 
$
2,489,768

Trade accounts receivable, less allowance for doubtful accounts
91,849

 

 
293,363

 

 
385,212

Other accounts receivable
19,033

 

 
30,390

 

 
49,423

Intergroup receivable
74,102

 

 
18,097

 
(92,199
)
 

Inventories
201,006

 

 
171,543

 
(14,188
)
 
358,361

Other current assets
45,901

 

 
25,111

 
(4,926
)
 
66,086

Total current assets
2,362,693

 

 
1,097,470

 
(111,313
)
 
3,348,850

Property, plant and equipment, at cost
1,726,690

 

 
893,980

 

 
2,620,670

Less accumulated depreciation and amortization
1,047,372

 

 
341,430

 

 
1,388,802

Net property, plant and equipment
679,318

 

 
552,550

 

 
1,231,868

Investments
73,500

 

 
120,542

 

 
194,042

Investment in subsidiaries
1,551,071

 

 

 
(1,551,071
)
 

Other assets
35,837

 

 
125,119

 

 
160,956

Goodwill
49,212

 

 
194,050

 

 
243,262

Other intangibles, net of amortization
20,834

 

 
23,291

 

 
44,125

Total assets
$
4,772,465

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103

Liabilities and Equity
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
122,479

 
$

 
$
109,226

 
$

 
$
231,705

Intergroup payable
18,097

 

 
74,102

 
(92,199
)
 

Accrued expenses
84,619

 

 
81,555

 

 
166,174

Current portion of long-term debt
692,280

 

 
18,816

 

 
711,096

Dividends payable
21,458

 

 

 

 
21,458

Income taxes payable
1,396

 

 
7,944

 
113

 
9,453

Total current liabilities
940,329

 

 
291,643

 
(92,086
)
 
1,139,886

Long-term debt
2,214,755

 

 
8,280

 

 
2,223,035

Postretirement benefits
56,424

 

 

 

 
56,424

Pension benefits
128,238

 

 
42,296

 

 
170,534

Other noncurrent liabilities
51,936

 

 
35,769

 

 
87,705

Deferred income taxes
21,318

 

 
35,566

 

 
56,884

Commitments and contingencies
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
Common stock
780

 

 
6,808

 
(6,808
)
 
780

Additional paid-in capital
10,447

 

 
553,172

 
(553,172
)
 
10,447

Accumulated other comprehensive loss
(62,413
)
 

 
(51,073
)
 
51,073

 
(62,413
)
Retained earnings
1,410,651

 

 
1,061,391

 
(1,061,391
)
 
1,410,651

Total Albemarle Corporation shareholders’ equity
1,359,465

 

 
1,570,298

 
(1,570,298
)
 
1,359,465

Noncontrolling interests

 

 
129,170

 

 
129,170

Total equity
1,359,465

 

 
1,699,468

 
(1,570,298
)
 
1,488,635

Total liabilities and equity
$
4,772,465

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103

Condensed Consolidating Balance Sheet
December 31, 2013
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
88,476

 
$

 
$
388,763

 
$

 
$
477,239

Trade accounts receivable, less allowance for doubtful accounts
149,834

 

 
297,030

 

 
446,864

Other accounts receivable
11,812

 

 
33,282

 

 
45,094

Intergroup receivable
88,090

 

 
28,433

 
(116,523
)
 

Inventories
219,390

 

 
234,975

 
(18,316
)
 
436,049

Other current assets
52,457

 

 
28,979

 
(3,767
)
 
77,669

Total current assets
610,059

 

 
1,011,462

 
(138,606
)
 
1,482,915

Property, plant and equipment, at cost
1,999,398

 

 
972,686

 

 
2,972,084

Less accumulated depreciation and amortization
1,268,205

 

 
346,810

 

 
1,615,015

Net property, plant and equipment
731,193

 

 
625,876

 

 
1,357,069

Investments
69,616

 

 
142,562

 

 
212,178

Investment in subsidiaries
1,611,662

 

 

 
(1,611,662
)
 

Other assets
18,621

 

 
141,608

 

 
160,229

Goodwill
49,212

 

 
234,991

 

 
284,203

Other intangibles, net of amortization
35,003

 

 
53,200

 

 
88,203

Total assets
$
3,125,366

 
$

 
$
2,209,699

 
$
(1,750,268
)
 
$
3,584,797

Liabilities and Equity
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
107,781

 
$

 
$
100,400

 
$

 
$
208,181

Intergroup payable
28,433

 

 
88,090

 
(116,523
)
 

Accrued expenses
92,273

 

 
84,143

 


 
176,416

Current portion of long-term debt
99

 

 
24,455

 

 
24,554

Dividends payable
19,197

 

 

 

 
19,197

Income taxes payable
2,364

 

 
5,651

 

 
8,015

Total current liabilities
250,147

 

 
302,739

 
(116,523
)
 
436,363

Long-term debt
1,035,977

 

 
18,333

 

 
1,054,310

Postretirement benefits
53,903

 

 

 

 
53,903

Pension benefits
20,931

 

 
36,716

 

 
57,647

Other noncurrent liabilities
61,095

 

 
49,515

 

 
110,610

Deferred income taxes
75,952

 

 
53,236

 

 
129,188

Commitments and contingencies
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
Common stock
801

 

 
6,807

 
(6,807
)
 
801

Additional paid-in capital
9,957

 

 
549,265

 
(549,265
)
 
9,957

Accumulated other comprehensive income
116,245

 

 
111,038

 
(111,038
)
 
116,245

Retained earnings
1,500,358

 

 
966,635

 
(966,635
)
 
1,500,358

Total Albemarle Corporation shareholders’ equity
1,627,361

 

 
1,633,745

 
(1,633,745
)
 
1,627,361

Noncontrolling interests

 

 
115,415

 

 
115,415

Total equity
1,627,361

 

 
1,749,160

 
(1,633,745
)
 
1,742,776

Total liabilities and equity
$
3,125,366

 
$

 
$
2,209,699

 
$
(1,750,268
)
 
$
3,584,797

Consolidating Statement of Income
Year Ended December 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,565,965

 
$

 
$
1,565,241

 
$
(685,658
)
 
$
2,445,548

Cost of goods sold
1,095,072

 

 
1,269,415

 
(689,787
)
 
1,674,700

Gross profit
470,893

 

 
295,826

 
4,129

 
770,848

Selling, general and administrative expenses
252,098

 

 
103,037

 

 
355,135

Research and development expenses
55,856

 

 
32,454

 

 
88,310

Restructuring and other charges, net
9,871

 

 
16,076

 

 
25,947

Acquisition and integration related costs
30,158

 

 

 

 
30,158

Intercompany service fee
26,123

 

 
(26,123
)
 

 

Operating profit
96,787

 

 
170,382

 
4,129

 
271,298

Interest and financing expenses
(41,361
)
 

 
3

 

 
(41,358
)
Other expenses, net
(10,534
)
 

 
(6,227
)
 

 
(16,761
)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments
44,892

 

 
164,158

 
4,129

 
213,179

Income tax expense
5,464

 

 
11,513

 
1,507

 
18,484

Income from continuing operations before equity in net income of unconsolidated investments
39,428

 

 
152,645

 
2,622

 
194,695

Equity in net income of unconsolidated investments (net of tax)
6,956

 

 
28,786

 

 
35,742

Net income from continuing operations
46,384

 

 
181,431

 
2,622

 
230,437

Loss from discontinued operations (net of tax)
(19,373
)
 

 
(50,158
)
 

 
(69,531
)
Equity in undistributed earnings of subsidiaries
106,305

 

 

 
(106,305
)
 

Net income
133,316

 

 
131,273

 
(103,683
)
 
160,906

Net income attributable to noncontrolling interests

 

 
(27,590
)
 

 
(27,590
)
Net income attributable to Albemarle Corporation
$
133,316

 
$

 
$
103,683

 
$
(103,683
)
 
$
133,316



Condensed Consolidating Statement of Comprehensive Loss
Year Ended December 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
133,316

 
$

 
$
131,273

 
$
(103,683
)
 
$
160,906

Total other comprehensive loss, net of tax
(178,658
)
 

 
(163,199
)
 
163,119

 
(178,738
)
Comprehensive loss
(45,342
)
 

 
(31,926
)
 
59,436

 
(17,832
)
Comprehensive income attributable to noncontrolling interests

 

 
(27,510
)
 

 
(27,510
)
Comprehensive loss attributable to Albemarle Corporation
$
(45,342
)
 
$

 
$
(59,436
)
 
$
59,436

 
$
(45,342
)
Condensed Consolidating Statement of Income
Year Ended December 31, 2013
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,563,483

 
$

 
$
1,437,664

 
$
(606,877
)
 
$
2,394,270

Cost of goods sold
1,025,989

 

 
1,131,158

 
(613,348
)
 
1,543,799

Gross profit
537,494

 

 
306,506

 
6,471

 
850,471

Selling, general and administrative expenses
60,818

 

 
97,371

 

 
158,189

Research and development expenses
51,794

 

 
30,452

 

 
82,246

Restructuring and other charges, net
23,880

 

 
9,481

 

 
33,361

Intercompany service fee
18,038

 

 
(18,038
)
 

 

Operating profit
382,964

 

 
187,240

 
6,471

 
576,675

Interest and financing expenses
(33,537
)
 

 
1,978

 

 
(31,559
)
Intergroup interest and financing expenses
(87
)
 

 
87

 

 

Other (expenses) income, net
(9,281
)
 

 
2,607

 

 
(6,674
)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments
340,059

 

 
191,912

 
6,471

 
538,442

Income tax expense
128,645

 

 
3,436

 
2,364

 
134,445

Income from continuing operations before equity in net income of unconsolidated investments
211,414

 

 
188,476

 
4,107

 
403,997

Equity in net income of unconsolidated investments (net of tax)
6,940

 

 
24,789

 

 
31,729

Net income from continuing operations
218,354

 

 
213,265

 
4,107

 
435,726

Income (loss) from discontinued operations (net of tax)
6,906

 

 
(2,798
)
 

 
4,108

Equity in undistributed earnings of subsidiaries
187,911

 

 

 
(187,911
)
 

Net income
413,171

 

 
210,467

 
(183,804
)
 
439,834

Net income attributable to noncontrolling interests

 

 
(26,663
)
 

 
(26,663
)
Net income attributable to Albemarle Corporation
$
413,171

 
$

 
$
183,804

 
$
(183,804
)
 
$
413,171



Condensed Consolidating Statement of Comprehensive Income (Loss)
Year Ended December 31, 2013
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
413,171

 
$

 
$
210,467

 
$
(183,804
)
 
$
439,834

Total other comprehensive income (loss), net of tax
30,981

 

 
(264,363
)
 
264,719

 
31,337

Comprehensive income (loss)
444,152

 

 
(53,896
)
 
80,915

 
471,171

Comprehensive income attributable to noncontrolling interests

 

 
(27,019
)
 

 
(27,019
)
Comprehensive income (loss) attributable to Albemarle Corporation
$
444,152

 
$

 
$
(80,915
)
 
$
80,915

 
$
444,152

Condensed Consolidating Statement of Income
Year Ended December 31, 2012
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,726,884

 
$

 
$
1,560,043

 
$
(767,773
)
 
$
2,519,154

Cost of goods sold
1,093,330

 

 
1,297,875

 
(770,894
)
 
1,620,311

Gross profit
633,554

 

 
262,168

 
3,121

 
898,843

Selling, general and administrative expenses
204,029

 

 
104,427

 

 
308,456

Research and development expenses
47,763

 

 
31,156

 

 
78,919

Restructuring and other charges, net
12,711

 

 
98,974

 

 
111,685

Intercompany service fee
26,132

 

 
(26,132
)
 

 

Operating profit
342,919

 

 
53,743

 
3,121

 
399,783

Interest and financing expenses
(33,193
)
 

 
393

 

 
(32,800
)
Other (expenses) income, net
(2,731
)
 

 
3,960

 

 
1,229

Income from continuing operations before income taxes and equity in net income of unconsolidated investments
306,995

 

 
58,096

 
3,121

 
368,212

Income tax expense (benefit)
80,444

 

 
(1,150
)
 
1,139

 
80,433

Income from continuing operations before equity in net income of unconsolidated investments
226,551

 

 
59,246

 
1,982

 
287,779

Equity in net income of unconsolidated investments (net of tax)
8,863

 

 
29,204

 

 
38,067

Net income from continuing operations
235,414

 

 
88,450

 
1,982

 
325,846

Income (loss) from discontinued operations (net of tax)
8,987

 

 
(4,706
)
 

 
4,281

Equity in undistributed earnings of subsidiaries
67,135

 

 

 
(67,135
)
 

Net income
311,536

 

 
83,744

 
(65,153
)
 
330,127

Net income attributable to noncontrolling interests

 

 
(18,591
)
 

 
(18,591
)
Net income attributable to Albemarle Corporation
$
311,536

 
$

 
$
65,153

 
$
(65,153
)
 
$
311,536



Condensed Consolidating Statement of Comprehensive Income
Year Ended December 31, 2012
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
311,536

 
$

 
$
83,744

 
$
(65,153
)
 
$
330,127

Total other comprehensive income, net of tax
24,935

 

 
44,721

 
(44,824
)
 
24,832

Comprehensive income
336,471

 

 
128,465

 
(109,977
)
 
354,959

Comprehensive income attributable to noncontrolling interests

 

 
(18,488
)
 

 
(18,488
)
Comprehensive income attributable to Albemarle Corporation
$
336,471

 
$

 
$
109,977

 
$
(109,977
)
 
$
336,471

Consolidating Statement Of Cash Flows
Year Ended December 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
88,476

 
$

 
$
388,763

 
$

 
$
477,239

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
227,426

 

 
273,176

 
(7,993
)
 
492,609

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(81,624
)
 

 
(28,952
)
 

 
(110,576
)
Cash proceeds from divestitures, net
97,523

 

 
7,195

 

 
104,718

Payment for settlement of interest rate swap
(33,425
)
 

 

 

 
(33,425
)
Sales of (investments in) marketable securities, net
668

 

 
(19
)
 

 
649

Long-term advances to joint ventures

 

 
(7,499
)
 

 
(7,499
)
Net cash used in investing activities
(16,858
)
 

 
(29,275
)
 

 
(46,133
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of senior notes
1,888,197

 

 

 

 
1,888,197

Repayments of long-term debt
(108
)
 

 
(5,909
)
 

 
(6,017
)
Other borrowings (repayments), net
4,178

 

 
(10,003
)
 

 
(5,825
)
Dividends paid to shareholders
(84,102
)
 

 

 

 
(84,102
)
Dividends paid to noncontrolling interests

 

 
(15,535
)
 

 
(15,535
)
Intercompany dividends paid

 

 
(7,993
)
 
7,993

 

Repurchases of common stock
(150,000
)
 

 

 

 
(150,000
)
Proceeds from exercise of stock options
2,713

 

 

 

 
2,713

Excess tax benefits realized from stock-based compensation arrangements
826

 

 

 

 
826

Withholding taxes paid on stock-based compensation award distributions
(3,284
)
 

 

 

 
(3,284
)
Debt financing costs
(17,644
)
 

 

 

 
(17,644
)
Net cash provided by (used in) financing activities
1,640,776

 

 
(39,440
)
 
7,993

 
1,609,329

Net effect of foreign exchange on cash and cash equivalents
(9,018
)
 

 
(34,258
)
 

 
(43,276
)
Increase in cash and cash equivalents
1,842,326

 

 
170,203

 

 
2,012,529

Cash and cash equivalents at end of year
$
1,930,802

 
$

 
$
558,966

 
$

 
$
2,489,768

Condensed Consolidating Statement Of Cash Flows
Year Ended December 31, 2013
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
145,999

 
$

 
$
331,697

 
$

 
$
477,696

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
270,179

 

 
177,806

 
(15,126
)
 
432,859

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(79,441
)
 

 
(75,905
)
 

 
(155,346
)
Cash payments related to acquisitions and other
(250
)
 

 
(2,315
)
 

 
(2,565
)
Sales of (investments in) marketable securities, net
186

 

 
(17
)
 

 
169

Proceeds from intercompany investing related activity
47,393

 

 
43,850

 
(91,243
)
 

Intercompany investing related payments

 

 
(43,850
)
 
43,850

 

Net cash used in investing activities
(32,112
)
 

 
(78,237
)
 
(47,393
)
 
(157,742
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(117,097
)
 

 
(18,636
)
 

 
(135,733
)
Proceeds from borrowings of long-term debt
117,000

 

 

 

 
117,000

Other borrowings, net
363,000

 

 
35,544

 

 
398,544

Dividends paid to shareholders
(78,107
)
 

 

 

 
(78,107
)
Dividends paid to noncontrolling interests

 

 
(10,014
)
 

 
(10,014
)
Intercompany dividends paid

 

 
(15,126
)
 
15,126

 

Repurchases of common stock
(582,298
)
 

 

 

 
(582,298
)
Proceeds from exercise of stock options
5,553

 

 

 

 
5,553

Excess tax benefits realized from stock-based compensation arrangements
3,266

 

 

 

 
3,266

Withholding taxes paid on stock-based compensation award distributions
(6,149
)
 

 

 

 
(6,149
)
Debt financing costs
(108
)
 

 

 

 
(108
)
Proceeds from intercompany financing related activity
43,850

 

 

 
(43,850
)
 

Intercompany financing related payments
(43,850
)
 

 
(47,393
)
 
91,243

 

Net cash used in financing activities
(294,940
)
 

 
(55,625
)
 
62,519

 
(288,046
)
Net effect of foreign exchange on cash and cash equivalents
(650
)
 

 
13,122

 

 
12,472

(Decrease) increase in cash and cash equivalents
(57,523
)
 

 
57,066

 

 
(457
)
Cash and cash equivalents at end of year
$
88,476

 
$

 
$
388,763

 
$

 
$
477,239

Condensed Consolidating Statement Of Cash Flows
Year Ended December 31, 2012
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
47,018

 
$

 
$
422,398

 
$

 
$
469,416

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
342,173

 

 
189,511

 
(42,918
)
 
488,766

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(136,299
)
 

 
(144,574
)
 

 
(280,873
)
Cash payments related to acquisitions and other
(3,072
)
 

 
(288
)
 

 
(3,360
)
Cash proceeds from divestitures, net

 

 
9,646

 

 
9,646

Investments in marketable securities, net
(1,607
)
 

 
(8
)
 

 
(1,615
)
Long-term advances to joint ventures
(2,459
)
 

 
(22,500
)
 

 
(24,959
)
Proceeds from intercompany investing related activity
39,851

 

 

 
(39,851
)
 

Intercompany investing related payments
(33,809
)
 

 

 
33,809

 

Net cash used in investing activities
(137,395
)
 

 
(157,724
)
 
(6,042
)
 
(301,161
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(86
)
 

 
(14,304
)
 

 
(14,390
)
Other borrowings (repayments), net
144

 

 
(49,565
)
 

 
(49,421
)
Dividends paid to shareholders
(69,113
)
 

 

 

 
(69,113
)
Dividends paid to noncontrolling interests

 

 
(7,628
)
 

 
(7,628
)
Intercompany dividends paid

 

 
(42,918
)
 
42,918

 

Repurchases of common stock
(63,575
)
 

 

 

 
(63,575
)
Proceeds from exercise of stock options
21,148

 

 

 

 
21,148

Excess tax benefits realized from stock-based compensation arrangements
14,809

 

 

 

 
14,809

Withholding taxes paid on stock-based compensation award distributions
(9,124
)
 

 

 

 
(9,124
)
Proceeds from intercompany financing related activity

 

 
33,809

 
(33,809
)
 

Intercompany financing related payments

 

 
(39,851
)
 
39,851

 

Net cash used in financing activities
(105,797
)
 

 
(120,457
)
 
48,960

 
(177,294
)
Net effect of foreign exchange on cash and cash equivalents

 

 
(2,031
)
 

 
(2,031
)
Increase (decrease) in cash and cash equivalents
98,981

 

 
(90,701
)
 

 
8,280

Cash and cash equivalents at end of year
$
145,999

 
$

 
$
331,697

 
$

 
$
477,696